Global Spotlight | YHLO Unveils iTLA Max at MEDLAB Dubai, Ushering in a New Era of Intelligent Diagnostics


On February 4, 2025, Shenzhen YHLO Biotech Co., Ltd. successfully launched the iTLA Max, total intelligent laboratory automation solution, at the MEDLAB Middle East 2025 exhibition in Dubai. As one of the largest and most influential medical laboratory exhibitions in the Middle East, MEDLAB ME attracted over 700 exhibitors and more than 27,000 professional attendees from around the world. YHLO's launch event became the focal point of the exhibition, drawing significant attention from global experts, distributors, and media representatives, who gathered to witness this important moment.
 


The release of iTLA Max marks another significant achievement for YHLO in the field of technological innovation and serves as a key milestone for the global medical diagnostics industry’s shift toward smart automation. This product integrates artificial intelligence, visual recognition, and automation technologies to provide a complete end-to-end automated solution for clinical laboratories—from sample reception and testing to analysis and report generation.

With a throughput of up to 1,200 samples per hour, iTLA Max boasts five core advantages: AI-powered visual insight, performance leaps, fast-track emergency processing, biosafety protection, and versatile compatibility. It is paired with the iCube Smart Information Management System, which helps laboratories achieve comprehensive quality management across the laboratory workflow cycle.

This innovative system not only significantly improves laboratory efficiency and reduces human errors but also provides strong support for the future of efficient, precise, and intelligent diagnostic medicine.

 

 

At the event, Mr. Li Wei, Director of the YHLO International Business Unit, extended heartfelt gratitude to the experts, distributors, and customers who have supported YHLO over the years. He highlighted that the launch of iTLA Max represents a new chapter in YHLO global strategic roadmap and conveyed his appreciation to all parties for their unwavering support and contributions. Mr. Li emphasized that the groundbreaking innovation of iTLA Max is set to revolutionize laboratory operations by significantly enhancing testing efficiency and driving the digital transformation of global medical diagnostics.

Distributors and customers from various countries also took the stage to express their congratulations on the successful launch of iTLA Max. Experts praised the system for showcasing YHLO’s exceptional R&D capabilities, recognizing it as a revolutionary breakthrough in technology that will drive the intelligent and automated development of global laboratory diagnostics. iTLA Max offers more precise and efficient solutions for clinical laboratories, setting a new standard for medical testing.

 

 

The iTLA Max Total Intelligent Laboratory Automation Solution represents YHLO’s latest breakthrough in laboratory automation and intelligence. Entirely self-developed, this innovative product incorporates advanced technologies such as artificial intelligence and visual recognition, seamlessly optimizing the laboratory workflow from pre-analytical to post-analytical stages.

Building on the advantages of existing market-leading systems, the iTLA Max features modular designs that adapt flexibly to laboratories of varying sizes and testing needs. It supports multi-platform and multidisciplinary connectivity, meeting healthcare providers' demands for remote data sharing and cloud-based system management.

Furthermore, iTLA Max was honored with the prestigious 2024 MUSE Design Gold Award for its outstanding functionality and aesthetic design, underscoring its innovative value in the industry.

 

 

In addition to iTLA Max, YHLO introduced the iCube Smart Laboratory Information Management System at the event. Equipped with advanced data analysis and device monitoring functionalities, iCube enhances equipment stability and accuracy. Its user-friendly interface allows real-time monitoring, remote control, and data analysis, further streamlining laboratory operations and management.

 

 

During the exhibition, YHLO also hosted its annual Dubai Distributor Gala Dinner, attracting nearly 100 representatives from over 40 countries. At the gala, YHLO presented awards including the "Outstanding Partner Award" and "Best Support Award" to honor its long-term collaborators and valued customers. In an atmosphere of joy and camaraderie, attendees received heartfelt thanks and blessings from YHLO while envisioning a shared future of progress in global medical diagnostics.

 

 

In his speech at the gala dinner, Mr. Li Wei, Director of the YHLO International Business Unit, reaffirmed YHLO's commitment to strengthening its international strategic presence. He highlighted the company’s plans to intensify investments in academic collaboration, technology development, and supply chain integration while working closely with global partners to advance the cause of global healthcare. YHLO will also focus on continuously enhancing its product and service offerings to expand their applications in the medical field, driving the digital transformation of global healthcare.

 

 

During the gala dinner, distributors and customers from around the world actively exchanged insights, sharing ideas on regional sales strategies and marketing initiatives. Their valuable discussions and collaborative spirit laid a solid foundation for mutual growth in the upcoming year.

With the successful conclusion of the launch event and gala dinner, YHLO has solidified its commitment to advancing intelligent diagnostics. Looking ahead, the company remains steadfast in its "Academia-Driven Sales" strategy, further expanding its global footprint and driving innovation in medical technology. By staying focused on delivering cutting-edge solutions, YHLO is poised to make even greater contributions to advancing global healthcare and pursuing excellence in the medical diagnostics field.

Attachments:


MORE NEWS